Skip to content
healthcare.dev

GUAIFENESIN

NDC 0121-2232, GUAIFENESIN, solution, from PAI Holdings, LLC dba PAI Pharma.

Product NDC
0121-2232
Status
Listed
Labeler
PAI Holdings, LLC dba PAI Pharma
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M012
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0121-2232 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN300 mg/15mL

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
0121-2232-000012122320010 TRAY in 1 CASE (0121-2232-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 15 mL in 1 CUP, UNIT-DOSE (0121-2232-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0121-2232 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0121-2232 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0121-2232. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.